135 related articles for article (PubMed ID: 7643977)
1. Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats.
Badie B; Drazan KE; Kramar MH; Shaked A; Black KL
Neurol Res; 1995 Jun; 17(3):209-16. PubMed ID: 7643977
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model.
Badie B; Hunt K; Economou JS; Black KL
Neurosurgery; 1994 Nov; 35(5):910-5; discussion 915-6. PubMed ID: 7838341
[TBL] [Abstract][Full Text] [Related]
3. Combined radiation and p53 gene therapy of malignant glioma cells.
Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
[TBL] [Abstract][Full Text] [Related]
4. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses.
Puumalainen AM; Vapalahti M; Agrawal RS; Kossila M; Laukkanen J; Lehtolainen P; Viita H; Paljärvi L; Vanninen R; Ylä-Herttuala S
Hum Gene Ther; 1998 Aug; 9(12):1769-74. PubMed ID: 9721087
[TBL] [Abstract][Full Text] [Related]
5. Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells.
Viola JJ; Ram Z; Walbridge S; Oshiro EM; Trapnell B; Tao-Cheng JH; Oldfield EH
J Neurosurg; 1995 Jan; 82(1):70-6. PubMed ID: 7815137
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of adenoviral p53 delivery with SCH58500 in the intracranial 9l and RG2 models.
Bowers G; He J; Schulz K; Olivarria G; Maneval D; Olson JJ
Front Biosci; 2003 May; 8():a54-61. PubMed ID: 12700117
[TBL] [Abstract][Full Text] [Related]
7. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
8. [Gene transduction for experimental brain tumors using recombinant adenovirus vector].
Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Ohmoto T; Yoshida Y; Hamada H
No To Shinkei; 1998 Aug; 50(8):731-8. PubMed ID: 9757466
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral vector-mediated gene transfer: timing of wild-type p53 gene expression in vivo and effect of tumor transduction on survival in a rat glioma brachytherapy model.
Bampoe J; Glen J; Hubbard SL; Salhia B; Shannon P; Rutka J; Bernstein M
J Neurooncol; 2000 Aug; 49(1):27-39. PubMed ID: 11131984
[TBL] [Abstract][Full Text] [Related]
10. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
13. Potentials and limitations of adenovirus-p53 gene therapy for brain tumors.
Hong YK; Joe YA; Yang YJ; Lee KS; Son BC; Jeun SS; Chung DS; Cho KK; Park CK; Kim MC; Kim HK; Yung WK; Kang JK
J Korean Med Sci; 2000 Jun; 15(3):315-22. PubMed ID: 10895975
[TBL] [Abstract][Full Text] [Related]
14. In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection.
Drazan KE; Shen XD; Csete ME; Zhang WW; Roth JA; Busuttil RW; Shaked A
Surgery; 1994 Aug; 116(2):197-203; discussion 203-4. PubMed ID: 8047986
[TBL] [Abstract][Full Text] [Related]
15. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors.
Badie B; Kramar MH; Lau R; Boothman DA; Economou JS; Black KL
J Neurooncol; 1998 May; 37(3):217-22. PubMed ID: 9524079
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S
Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells.
Shinoura N; Hamada H
Curr Gene Ther; 2003 Apr; 3(2):147-53. PubMed ID: 12653407
[TBL] [Abstract][Full Text] [Related]
20. Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma.
Hannay J; Davis JJ; Yu D; Liu J; Fang B; Pollock RE; Lev D
Gene Ther; 2007 Apr; 14(8):671-81. PubMed ID: 17287860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
